Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $454.58
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 12, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 15, 26 | Ghazi Sassine | director, officer: PRESIDENT AND CEO | M-Exempt | 14,604 @ $135.88 | $1.98M |
Daily · Wilder smoothing
| Needham |
| maintain |
| Buy |
| Buy |
| Oct 1, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Oct 1, 26 | Keybanc | maintain | Overweight | Overweight |
| Oct 1, 26 | Rosenblatt | maintain | Buy | Buy |
| Sep 25, 26 | HSBC | upgrade | Hold | Buy |
| Sep 24, 26 | BNP Paribas | upgrade | Underperform | Neutral |
| Sep 10, 26 | Wells Fargo | upgrade | Equal Weight | Overweight |
| Sep 8, 26 | Morgan Stanley | upgrade | Equal Weight | Overweight |
| Aug 27, 26 | Benchmark | maintain | Buy | Buy |
| Oct 15, 26 |
| Ghazi Sassine |
| director, officer: PRESIDENT AND CEO |
| S-Sale |
| 14,604 @ $462.84 |
| $6.76M |
| Oct 15, 26 | Ghazi Sassine | director, officer: PRESIDENT AND CEO | M-Exempt | 14,604 @ $135.88 | $1.98M |
| Oct 6, 26 | Lee Janet | officer: GC & Corporate Secretary | S-Sale | 584 @ $502.64 | $293.3K |
| Oct 6, 26 | Lee Janet | officer: GC & Corporate Secretary | S-Sale | 560 @ $502.40 | $281.3K |
| Oct 6, 26 | Kankanwadi Sudhindra | officer: Deputy CFO & CAO | M-Exempt | 9,170 @ $135.88 | $1.25M |
| Oct 5, 26 | Kankanwadi Sudhindra | officer: Deputy CFO & CAO | M-Exempt | 3,000 @ $135.88 | $407.6K |
| Oct 6, 26 | Kankanwadi Sudhindra | officer: Deputy CFO & CAO | S-Sale | 9,170 @ $500.00 | $4.58M |
Classic floor pivots from 2026-10-19
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 49.76 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 48.93 | Oscillator | Neutral |
| Williams %R (14) | -59.55 | Oscillator | Neutral |
| MACD (12, 26, 9) | 15.32 (Hist -4.50) | Oscillator | Sell |
| Average Directional Index (14) | 23.61 (+DI 25.1 / -DI 27.8) | Trend | Sell |
| EMA 20 | 462.67 | MA | Sell |
| SMA 20 | 463.97 | MA | Sell |
| EMA 50 | 441.74 | MA | Buy |
| SMA 50 | 428.78 | MA | Strong Buy |
| SMA 200 | 445.84 | MA | Buy |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
In the most recent trading session, Synopsys (SNPS) closed at $422.48, indicating a -6.36% shift from the previous trading day.
Synopsys builds the software that powers every chip designed for AI, and analysts are practically falling over each other to buy it.
Synopsys, Inc. (NASDAQ: SNPS - Get Free Report) CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the sale, the chief executive officer directly owned 76,865 shares in the company, valued at
SNPS is expanding its AI-focused Design IP business as demand for high-speed connectivity grows, with rising design wins and automotive adoption supporting growth.
Electronic design automation (EDA) company Synopsys NASDAQ: SNPS is coming off one of its strongest stretches of 2026, with shares up 30% over the past month.
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Synopsys could emerge as a major winner from the next phase of AI growth, but its ambitious 2030 targets come with important valuation risks.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 26, 2026 | 3.67 | 3.91 | Beat 6.5% | $2.48B |
| May 27, 2026 | 3.15 | 3.35 | Beat 6.3% | $2.28B |
| Feb 25, 2026 | 3.56 | 3.77 | Beat 5.9% | $2.41B |
| Dec 10, 2025 | 2.78 | 2.90 | Beat 4.3% | $2.25B |
| Sep 9, 2025 | 3.80 | 3.39 | Miss -10.8% | $1.74B |
| May 28, 2025 | 3.39 | 3.67 | Beat 8.3% | $1.60B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 16, 2026 | 2026-10-16 17:42:43 | View |
| 4 | Oct 7, 2026 | 2026-10-07 18:35:34 | View |
| 4 | Oct 6, 2026 | 2026-10-06 19:34:08 | View |
| 8-K | Oct 5, 2026 | 2026-10-05 09:21:53 | View |
| 4 | Sep 16, 2026 | 2026-09-16 16:11:03 | View |
| 4 | Sep 14, 2026 | 2026-09-14 16:28:16 | View |
| 4 | Sep 2, 2026 | 2026-09-02 15:48:51 | View |
| 4 | Sep 2, 2026 | 2026-09-02 15:35:26 | View |
| 4 | Sep 2, 2026 | 2026-09-02 15:29:06 | View |
| 4 | Sep 2, 2026 | 2026-09-02 15:19:41 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | SNPS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 78.9x | 52.1x · sector 44.2x | Elevated |
| Forward P/E (FY26E) | 30.0x | EPS est. 15.15 | Discount |
| Price / Book | 2.8x | 8.1x | Discount |
| Price / Sales | 9.3x | 11.6x | Discount |
| EV / EBITDA | 25.3x | 40.4x | Discount |
| Return on equity | 3.6% | — | Weak |
| Gross margin | 72.4% | 79.5% | In line |
| Debt / Equity | 0.35 | 0.19 | Conservative |
| Piotroski / Altman Z | 5/9 | Z 3.85 | Safe zone |
Discounted cash flow model